• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰腺癌中的胆固醇代谢及相关治疗策略。

Cholesterol metabolism in pancreatic cancer and associated therapeutic strategies.

作者信息

Daya Tasvi, Breytenbach Andrea, Gu Liang, Kaur Mandeep

机构信息

School of Molecular and Cell Biology, University of the Witwatersrand, Private Bag 3, WITS, 2050 Johannesburg, South Africa.

School of Molecular and Cell Biology, University of the Witwatersrand, Private Bag 3, WITS, 2050 Johannesburg, South Africa.

出版信息

Biochim Biophys Acta Mol Cell Biol Lipids. 2025 Mar;1870(2):159578. doi: 10.1016/j.bbalip.2024.159578. Epub 2024 Nov 13.

DOI:10.1016/j.bbalip.2024.159578
PMID:39542394
Abstract

Pancreatic cancer remains one of the most lethal cancers due to late diagnosis and high chemoresistance. Despite recent progression in the development of chemotherapies, immunotherapies, and potential nanoparticles-based approaches, the success rate of therapeutic response is limited which is further compounded by cancer drug resistance. Understanding of emerging biological and molecular pathways causative of pancreatic cancer's aggressive and chemoresistance is vital to improve the effectiveness of existing therapeutics and to develop new therapies. One such under-investigated and relatively less explored area of research is documenting the effect that lipids, specifically cholesterol, and its metabolism, impose on pancreatic cancer. Dysregulated cholesterol metabolism has a profound role in supporting cellular proliferation, survival, and promoting chemoresistance and this has been well established in various other cancers. Thus, we aimed to provide an in-depth review focusing on the significance of cholesterol metabolism in pancreatic cancer and relevant genes at play, molecular processes contributing to cellular cholesterol homeostasis, and current research efforts to develop new cholesterol-targeting therapeutics. We highlight the caveats, weigh in different experimental therapeutic strategies, and provide possible suggestions for future research highlighting cholesterol's importance as a therapeutic target against pancreatic cancer resistance and cancer progression.

摘要

由于诊断较晚和高化疗耐药性,胰腺癌仍然是最致命的癌症之一。尽管最近在化疗、免疫治疗以及潜在的基于纳米颗粒的方法的开发方面取得了进展,但治疗反应的成功率仍然有限,而癌症耐药性进一步加剧了这一问题。了解导致胰腺癌侵袭性和化疗耐药性的新出现的生物学和分子途径,对于提高现有治疗方法的有效性和开发新疗法至关重要。一个研究不足且相对较少探索的研究领域是记录脂质,特别是胆固醇及其代谢对胰腺癌的影响。胆固醇代谢失调在支持细胞增殖、存活以及促进化疗耐药性方面具有重要作用,这在其他各种癌症中已得到充分证实。因此,我们旨在提供一篇深入综述,重点关注胆固醇代谢在胰腺癌中的重要性以及相关基因的作用、有助于细胞胆固醇稳态的分子过程,以及目前开发新的胆固醇靶向治疗方法的研究工作。我们强调了注意事项,权衡了不同的实验性治疗策略,并为未来研究提供了可能的建议,突出了胆固醇作为对抗胰腺癌耐药性和癌症进展的治疗靶点的重要性。

相似文献

1
Cholesterol metabolism in pancreatic cancer and associated therapeutic strategies.胰腺癌中的胆固醇代谢及相关治疗策略。
Biochim Biophys Acta Mol Cell Biol Lipids. 2025 Mar;1870(2):159578. doi: 10.1016/j.bbalip.2024.159578. Epub 2024 Nov 13.
2
Targeting lipid metabolism: novel insights and therapeutic advances in pancreatic cancer treatment.靶向脂质代谢:胰腺癌治疗的新见解与治疗进展
Lipids Health Dis. 2025 Jan 13;24(1):12. doi: 10.1186/s12944-024-02426-0.
3
Undermining Glutaminolysis Bolsters Chemotherapy While NRF2 Promotes Chemoresistance in KRAS-Driven Pancreatic Cancers.破坏谷氨酰胺分解增强化疗效果,而 NRF2 促进 KRAS 驱动的胰腺癌细胞的化疗耐药性。
Cancer Res. 2020 Apr 15;80(8):1630-1643. doi: 10.1158/0008-5472.CAN-19-1363. Epub 2020 Jan 7.
4
Chemoresistance in pancreatic ductal adenocarcinoma: Overcoming resistance to therapy.胰腺导管腺癌的化疗耐药性:克服治疗耐药性。
Adv Cancer Res. 2023;159:285-341. doi: 10.1016/bs.acr.2023.02.010. Epub 2023 Apr 18.
5
Molecular and cellular mechanisms of chemoresistance in pancreatic cancer.胰腺癌化疗耐药的分子和细胞机制
Adv Biol Regul. 2018 May;68:77-87. doi: 10.1016/j.jbior.2017.11.007. Epub 2017 Nov 22.
6
Suppression of STAT5b in pancreatic cancer cells leads to attenuated gemcitabine chemoresistance, adhesion and invasion.胰腺癌细胞中STAT5b的抑制导致吉西他滨化疗耐药性、黏附及侵袭能力减弱。
Oncol Rep. 2016 Jun;35(6):3216-26. doi: 10.3892/or.2016.4727. Epub 2016 Apr 1.
7
Molecular alterations contributing to pancreatic cancer chemoresistance.导致胰腺癌化疗耐药的分子改变。
Pancreatology. 2017 Mar-Apr;17(2):310-320. doi: 10.1016/j.pan.2016.12.013. Epub 2016 Dec 28.
8
Targeting the sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drug.靶向鞘脂代谢以克服胰腺癌细胞对化疗药物吉西他滨的耐药性。
Mol Cancer Ther. 2009 Apr;8(4):809-20. doi: 10.1158/1535-7163.MCT-08-1096.
9
Metabolic reprogramming of drug resistance in pancreatic cancer: mechanisms and effects.胰腺癌耐药中的代谢重编程:机制与影响
Mol Aspects Med. 2025 Jun;103:101368. doi: 10.1016/j.mam.2025.101368. Epub 2025 May 20.
10
Pancreatic ductal adenocarcinoma chemoresistance: From metabolism reprogramming to novel treatment.胰腺导管腺癌的化疗耐药性:从代谢重编程到新疗法
Chin Med J (Engl). 2024 Feb 20;137(4):408-420. doi: 10.1097/CM9.0000000000002758. Epub 2023 Aug 4.

引用本文的文献

1
Smart Drug Delivery Systems Based on Cyclodextrins and Chitosan for Cancer Therapy.基于环糊精和壳聚糖的智能药物递送系统用于癌症治疗
Pharmaceuticals (Basel). 2025 Apr 13;18(4):564. doi: 10.3390/ph18040564.
2
Impact of Nutritional Changes on the Prognosis in Pancreatic Cancer Patients Underwent Curative Surgery After Neoadjuvant Chemotherapy.营养变化对新辅助化疗后接受根治性手术的胰腺癌患者预后的影响
Nutrients. 2025 Feb 11;17(4):647. doi: 10.3390/nu17040647.
3
Targeting lipid metabolism: novel insights and therapeutic advances in pancreatic cancer treatment.
靶向脂质代谢:胰腺癌治疗的新见解与治疗进展
Lipids Health Dis. 2025 Jan 13;24(1):12. doi: 10.1186/s12944-024-02426-0.